Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03595111
Other study ID # IRB00008715964
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 2018
Est. completion date December 2018

Study information

Verified date July 2018
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite major advances in the technical aspects of surgical repair of congenital heart diseases, perioperative myocardial damage with low cardiac output remains the most common cause of morbidity and death after repair of congenital heart lesions.


Description:

Myocardial sample was obtained from the endocardial surface of the right ventricle and placed in formalin until examination under light microscopy for detection of myocyte cellular edema as a marker of ischemic changes.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 2018
Est. primary completion date November 2018
Accepts healthy volunteers No
Gender All
Age group 2 Years to 6 Years
Eligibility Inclusion Criteria:

Scheduled cardiac surgery requiring cardioplegic arrest with expected cross clamp time>45 minutes.

Hemodynamic stability.

Exclusion Criteria:

Previous cardiac surgery. Urgent or emergent cases. Any known allergies to components of either cardioplegia solutions.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
myocardial biopsy
Myocardial cell edema either focal or diffuse was detected in histopathological examination

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Myocardial biopsy Myocardial cell edema either focal or diffuse was detected in histopathological examination within 24 hours
Secondary The inotropic score 1 point is assigned for each mcg/kg/min of dopamine and dobutamine, and 10 points is assigned for each 0.1 mcg/kg/min of epinephrine, norepinephrine, and phenylephrine. (i.e. 1 point is assigned for each 10 ng/kg/min of epinephrine, norepinephrine, and phenylephrine. within one month
Secondary Serum cardiac troponin level Samples for troponin I levels at baseline, 6, 12 and 24 hours after aortic cross-clamping. first 24 hours
Secondary 30-day mortality number of patients died 30 days
Secondary Type of cardiac rhythm on return Type of cardiac rhythm on return within 24 hours
See also
  Status Clinical Trial Phase
Completed NCT00546390 - Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study N/A
Completed NCT01941420 - Comparison of Blood and Crystalloid Cardioplegia N/A
Completed NCT01941459 - Comparison of Blood Cardioplegia and Custodiol N/A
Completed NCT03859115 - Effects of TENS on Myocardial Protection in Patients Undergoing AVR N/A
Completed NCT04231903 - Myocardial Protection in Minimally Invasive Mitral Valve Surgery
Completed NCT06287372 - Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia
Completed NCT00610350 - Levosimendan and Myocardial Protection Phase 4